ESSA Pharma to Present at the Jefferies Virtual Healthcare Conference
News provided by
Share this article
Share this article
HOUSTON, Texas and VANCOUVER, Canada, May 25, 2021 /PRNewswire/ - ESSA Pharma Inc. ( ESSA or the Company ) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, Chief Executive Officer of ESSA, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference. Dr. Parkinson, along with Peter Virsik, ESSA s Chief Operating Officer, and David S. Wood, ESSA s Chief Financial Officer, will be available for one-on-one meetings. The conference will take place from June 1 – June 4, 2021.
About Inventiva
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need.
Leveraging its expertise and experience in the domain of compounds targeting nuclear receptors, transcription factors and epigenetic modulation, Inventiva is currently advancing two clinical candidates, as well as a deep pipeline of earlier stage programs.
Lanifibranor, its lead product candidate, is being developed for the treatment of patients with NASH, a common and progressive chronic liver disease for which there are currently no approved therapies. In 2020, Inventiva announced positive topline data from its Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH and obtained Breakthrough Therapy and Fast Track designation for lanifibranor in the treatment of NASH.
Quest Diagnostics To Speak At The Jefferies Virtual Healthcare Conference
News provided by
Share this article
Share this article
SECAUCUS, N.J., May 19, 2021 /PRNewswire/ Quest Diagnostics Incorporated (NYSE: DGX), the world s leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference. Steve Rusckowski, Chairman, CEO and President, will discuss the company s vision, goals, and capital deployment strategies. The presentation is scheduled for Thursday, June 3, 2021 at 8:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available on the company s investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until July 3, 2021.
Message :
Required fields
SECAUCUS, N.J., May 19, 2021 /PRNewswire/ Quest Diagnostics Incorporated (NYSE: DGX), the world s leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference. Steve Rusckowski, Chairman, CEO and President, will discuss the company s vision, goals, and capital deployment strategies. The presentation is scheduled for Thursday, June 3, 2021 at 8:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available on the company s investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until July 3, 2021.